tpj12090-sup-0001-FigureS1.tifimage/tif7253KFigure S1. Time-dependent onset of the cpk28 phenotype.
tpj12090-sup-0002-FigureS2.tifimage/tif192KFigure S2. Reversal of cpk28 mutant characteristics in complementation lines.
tpj12090-sup-0003-FigureS3.tifimage/tif3035KFigure S3. Expression level of CPK28 in transgenic lines.
tpj12090-sup-0004-FigureS4.tifimage/tif1634KFigure S4. Complementation of the cpk28 stem elongation phenotype by tissue-specific expression of CPK28.
tpj12090-sup-0005-FigureS5.tifimage/tif1843KFigure S5. In vivo phosphorylation sites of CPK28.
tpj12090-sup-0006-FigureS6.tifimage/tif86KFigure S6. Calcium-dependent kinase activity of CPK28 phosphorylation variants.
tpj12090-sup-0007-FigureS7.tifimage/tif1273KFigure S7. In vivo complementation of the cpk28 stem elongation phenotype by different CPK28 phosphorylation variants.
tpj12090-sup-0008-FigureS8.tifimage/tif4877KFigure S8. Additional hormone treatments of WT and cpk28 mutants.
tpj12090-sup-0009-FigureS9.tifimage/tif123KFigure S9. Reduced GA biosynthesis gene expression of cpk28 mutants is reversed in complementation lines.
tpj12090-sup-0010-FigureS10.tifimage/tif227KFigure S10. Early GA-responses are not disturbed in cpk28 mutants.
tpj12090-sup-0011-FigureS11.tifimage/tif15926KFigure S11. Impact of exogenous gibberellic acid on secondary growth in cpk28.
tpj12090-sup-0012-FigureS12.tifimage/tif926KFigure S12. Scheme for CPK28 function.
tpj12090-sup-0013-TableS1.xlsxapplication/msexcel14KTable S1. Primer sequences used in this study.
tpj12090-sup-0014-Legends.docWord document27K 
tpj12090-sup-0015-MethodsS1.docxWord document23KMethods S1. Supplemental experimental procedures.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.